LOS ANGELES (AP) - The national furor over rising drug prices is moving to the ballot box in California, where voters will decide how the state negotiates for prescription medications.
The stakes are high: How trendsetting California votes could spill over to other states.
That possibility is not lost on the pharmaceutical industry, which has faced withering criticism for its huge profits and examples of massive price hikes, such as Turing Pharmaceuticals raising by 5,000 percent the cost of a drug for a life-threatening parasitic infection and Mylan's popular EpiPens costing $608 for a two-pack, an increase of more than 500 percent since 2007.
Big pharma spending big dollars to defeat California measure
Aucun commentaire:
Enregistrer un commentaire